Think HIV
Open Access
- 27 September 1999
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 159 (17) , 1994-2000
- https://doi.org/10.1001/archinte.159.17.1994
Abstract
More than 1 million people in the United States are estimated to be infected with the human immunodeficiency virus (HIV), a national prevalence of 0.3%.1 About half of those infected are men who have sex with men and a quarter are injection drug users. The incidence of HIV infection appears to have leveled off among men who have sex with men but continues to rise in injection drug users, women, and persons who have acquired HIV infection through heterosexual contact.2This publication has 38 references indexed in Scilit:
- HIV/AIDS Surveillance reportsChoice Reviews Online, 2002
- Randomised placebo-controlled trial of ritonavir in advanced HIV-1 diseaseThe Lancet, 1998
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic MillimeterNew England Journal of Medicine, 1996
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- HIV positive patients first presenting with an AIDS defining illness: characteristics and survivalBMJ, 1995
- Factors associated with initiation of primary medical care for HIV-infected personsThe American Journal of Medicine, 1994
- Factors associated with lack of awareness of HIV infection before diagnosis of AIDS.BMJ, 1993
- Incubation period of AIDS in San FranciscoNature, 1989